Intrathoracic far-field electrocardiogram allows continuous monitoring of ischemia after total coronary occlusion

被引:8
作者
Asbach, Stefan
Weiss, Ingo
Wenzel, Beate
Bode, Christoph
Zehender, Manfred
机构
[1] Univ Klinikum, Med Klin 3, Freiburg, Germany
[2] Biotron GmbH & Co KG, Study Ctr Erlangen, Erlangen, Germany
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2006年 / 29卷 / 12期
关键词
cardioverter-defibrillator; intrathoracic far-field electrocardiogram; myocardial ischemia; continuous monitoring;
D O I
10.1111/j.1540-8159.2006.00544.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Recording of intrathoracic far-field electrocardiograms (FF-ECG) via can and electrodes of implantable cardioverter-defibrillators (ICD) is a promising method for continuous monitoring of myocardial ischemia. We assessed the hypothesis that experimentally induced ischemia provokes segment changes in the FF-ECG that can be detected by the ICD. Methods and Results: In seven pigs with on ICD implanted in the left pectoral region and electrodes placed in the right ventricle and the superior vena cava, we occluded all major coronary arteries in proximal and distal locations for 180 s each. Surface and FF-ECGs were compared for presence and time course of ischemic ST segment changes. Reliable detection of ischemia by ST segment analysis was possible in all (38/38) experiments. Maximum deviation from baseline was larger in FF-ECG (1.21 mV) than surface ECG leads (0.23 mV, P < 0.01) for all occlusion sites. Ischemia could be detected earlier (P < 0.05) in the FF-ECG, with a sensitivity of 100%, 93%, and 100% after occlusions in the left anterior descending, left circumflex, and right coronary arteries, respectively. Conclusion: Intrathoracic FF-ECG allows reliable and reproducible detection of experimentally induced ischemia originating from all major coronary arteries and therefore could be an interesting tool for clinicians in monitoring high risk patients.
引用
收藏
页码:1334 / 1340
页数:7
相关论文
共 16 条
[1]  
*AM HEART ASS, 2003, HEART DIS STROK STAT, P1
[2]   A randomized study of the prevention of sudden death in patients with coronary artery disease [J].
Buxton, AE ;
Lee, KL ;
Fisher, JD ;
Josephson, ME ;
Prystowsky, EN ;
Hafley, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) :1882-1890
[3]   Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone [J].
Connolly, SJ ;
Gent, M ;
Roberts, RS ;
Dorian, P ;
Roy, D ;
Sheldon, RS ;
Mitchell, LB ;
Green, MS ;
Klein, GJ ;
O'Brien, B .
CIRCULATION, 2000, 101 (11) :1297-1302
[4]   SILENT-MYOCARDIAL-ISCHEMIA - A CLINICAL PERSPECTIVE [J].
DEEDWANIA, PC ;
CARBAJAL, EV .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (12) :2373-2382
[5]   Myocardial perfusion imaging following percutaneous coronary intervention - The importance of restenosis, disease progression, and directed reintervention [J].
Giedd, KN ;
Bergmann, SR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (03) :328-336
[6]  
Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09
[7]  
Grom A, 2002, BIOMED TECH, V47, P234
[8]   Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest -: The Cardiac Arrest Study Hamburg (CASH) [J].
Kuck, KH ;
Cappato, R ;
Siebels, J ;
Rüppel, R .
CIRCULATION, 2000, 102 (07) :748-754
[9]  
McAnulty J, 1997, NEW ENGL J MED, V337, P1576
[10]   PROGNOSTIC-SIGNIFICANCE OF PROGRESSION OF CORONARY-ARTERY DISEASE [J].
MOISE, A ;
BOURASSA, MG ;
THEROUX, P ;
TAEYMANS, Y ;
PASTERNAC, A ;
CAMPEAU, L ;
BOIS, MA ;
DYRDA, I ;
DAVID, PR .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (08) :941-946